APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biodegradable Coronary Stents

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Biodegradable Coronary Stents Market Outlook and Growth Opportunities 2026

27 December 2025203 pages

Choose your research edition.

Industry ResearchBiodegradable Coronary Stents Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Biodegradable Coronary Stents Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Biodegradable Coronary Stents Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biodegradable Coronary Stents Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Biodegradable Coronary Stents Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Biodegradable Coronary Stents market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Biodegradable Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biodegradable Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biodegradable Coronary Stents is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Biodegradable Coronary Stents market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Biodegradable Coronary Stents market include Abbott, Terumo, Shandong Huaan Biotechnology, Boston Scientific, Wego Healthcare, SMT, SINOMED, REVA Medical (1) and Q3 Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biodegradable Coronary Stents market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biodegradable Coronary Stents and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biodegradable Coronary Stents sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biodegradable Coronary Stents market size, projected growth trends, production technologies, key applications, and end-use industries.

Biodegradable Coronary Stents Segment by Company

Abbott

Terumo

Shandong Huaan Biotechnology

Boston Scientific

Wego Healthcare

SMT

SINOMED

REVA Medical (1)

Q3 Medical

Lepu Medical

Kyoto Medical

Elixir Medical

Cardionovum

Biotronik

Arterius

AMG International

Amaranth Medical

3M

Biodegradable Coronary Stents Segment by Type

Polylactic Acid (PLA)

Magnesium Alloys

Others

Biodegradable Coronary Stents Segment by Application

Percutaneous Coronary Intervention (PCI)

Post-Procedure Management

Drug-Eluting

Biodegradable Coronary Stents Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biodegradable Coronary Stents status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Biodegradable Coronary Stents market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biodegradable Coronary Stents significant trends, drivers, influence factors in global and regions.

6. To analyze Biodegradable Coronary Stents competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biodegradable Coronary Stents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biodegradable Coronary Stents and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biodegradable Coronary Stents.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biodegradable Coronary Stents market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biodegradable Coronary Stents industry.

Chapter 3: Detailed analysis of Biodegradable Coronary Stents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Biodegradable Coronary Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Biodegradable Coronary Stents in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biodegradable Coronary Stents Industry Trends Table 2. Biodegradable Coronary Stents Industry Drivers Table 3. Biodegradable Coronary Stents Industry Opportunities and Challenges Table 4. Biodegradable Coronary Stents Industry Restraints Table 5. Global Biodegradable Coronary Stents Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biodegradable Coronary Stents Revenue Share by Company (2021-2026) Table 7. Global Biodegradable Coronary Stents Sales Volume by Company (Units) & (2021-2026) Table 8. Global Biodegradable Coronary Stents Sales Volume Share by Company (2021-2026) Table 9. Global Biodegradable Coronary Stents Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Biodegradable Coronary Stents Company Ranking, (2024-2026) & (USD Million) Table 11. Global Biodegradable Coronary Stents Key Company Manufacturing Base & Headquarters Table 12. Global Biodegradable Coronary Stents Company, Product Type & Application Table 13. Global Biodegradable Coronary Stents Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Biodegradable Coronary Stents by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Polylactic Acid (PLA) Table 18. Significant Companies of Magnesium Alloys Table 19. Significant Companies of Others Table 20. Global Biodegradable Coronary Stents Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Biodegradable Coronary Stents Sales Volume by Type (2021-2026) & (Units) Table 22. Global Biodegradable Coronary Stents Sales Volume by Type (2027-2032) & (Units) Table 23. Global Biodegradable Coronary Stents Sales Volume Share by Type (2021-2026) Table 24. Global Biodegradable Coronary Stents Sales Volume Share by Type (2027-2032) Table 25. Global Biodegradable Coronary Stents Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Biodegradable Coronary Stents Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Biodegradable Coronary Stents Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Biodegradable Coronary Stents Sales Value Share by Type (2021-2026) Table 29. Global Biodegradable Coronary Stents Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Percutaneous Coronary Intervention (PCI) Table 31. Significant Companies of Post-Procedure Management Table 32. Significant Companies of Drug-Eluting Table 33. Global Biodegradable Coronary Stents Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 34. Global Biodegradable Coronary Stents Sales Volume by Application (2021-2026) & (Units) Table 35. Global Biodegradable Coronary Stents Sales Volume by Application (2027-2032) & (Units) Table 36. Global Biodegradable Coronary Stents Sales Volume Share by Application (2021-2026) Table 37. Global Biodegradable Coronary Stents Sales Volume Share by Application (2027-2032) Table 38. Global Biodegradable Coronary Stents Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Biodegradable Coronary Stents Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Biodegradable Coronary Stents Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Biodegradable Coronary Stents Sales Value Share by Application (2021-2026) Table 42. Global Biodegradable Coronary Stents Sales Value Share by Application (2027-2032) Table 43. Global Biodegradable Coronary Stents Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 44. Global Biodegradable Coronary Stents Sales by Region (2021-2026) & (Units) Table 45. Global Biodegradable Coronary Stents Sales Market Share by Region (2021-2026) Table 46. Global Biodegradable Coronary Stents Sales by Region (2027-2032) & (Units) Table 47. Global Biodegradable Coronary Stents Sales Market Share by Region (2027-2032) Table 48. Global Biodegradable Coronary Stents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Biodegradable Coronary Stents Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Biodegradable Coronary Stents Sales Value Share by Region (2021-2026) Table 51. Global Biodegradable Coronary Stents Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Biodegradable Coronary Stents Sales Value Share by Region (2027-2032) Table 53. Global Biodegradable Coronary Stents Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Biodegradable Coronary Stents Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Biodegradable Coronary Stents Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Global Biodegradable Coronary Stents Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Biodegradable Coronary Stents Sales by Country (2021-2026) & (Units) Table 58. Global Biodegradable Coronary Stents Sales Market Share by Country (2021-2026) Table 59. Global Biodegradable Coronary Stents Sales by Country (2027-2032) & (Units) Table 60. Global Biodegradable Coronary Stents Sales Market Share by Country (2027-2032) Table 61. Global Biodegradable Coronary Stents Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Biodegradable Coronary Stents Sales Value Market Share by Country (2021-2026) Table 63. Global Biodegradable Coronary Stents Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Biodegradable Coronary Stents Sales Value Market Share by Country (2027-2032) Table 65. Abbott Company Information Table 66. Abbott Business Overview Table 67. Abbott Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Abbott Biodegradable Coronary Stents Product Portfolio Table 69. Abbott Recent Development Table 70. Terumo Company Information Table 71. Terumo Business Overview Table 72. Terumo Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Terumo Biodegradable Coronary Stents Product Portfolio Table 74. Terumo Recent Development Table 75. Shandong Huaan Biotechnology Company Information Table 76. Shandong Huaan Biotechnology Business Overview Table 77. Shandong Huaan Biotechnology Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Shandong Huaan Biotechnology Biodegradable Coronary Stents Product Portfolio Table 79. Shandong Huaan Biotechnology Recent Development Table 80. Boston Scientific Company Information Table 81. Boston Scientific Business Overview Table 82. Boston Scientific Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Boston Scientific Biodegradable Coronary Stents Product Portfolio Table 84. Boston Scientific Recent Development Table 85. Wego Healthcare Company Information Table 86. Wego Healthcare Business Overview Table 87. Wego Healthcare Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Wego Healthcare Biodegradable Coronary Stents Product Portfolio Table 89. Wego Healthcare Recent Development Table 90. SMT Company Information Table 91. SMT Business Overview Table 92. SMT Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. SMT Biodegradable Coronary Stents Product Portfolio Table 94. SMT Recent Development Table 95. SINOMED Company Information Table 96. SINOMED Business Overview Table 97. SINOMED Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. SINOMED Biodegradable Coronary Stents Product Portfolio Table 99. SINOMED Recent Development Table 100. REVA Medical (1) Company Information Table 101. REVA Medical (1) Business Overview Table 102. REVA Medical (1) Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. REVA Medical (1) Biodegradable Coronary Stents Product Portfolio Table 104. REVA Medical (1) Recent Development Table 105. Q3 Medical Company Information Table 106. Q3 Medical Business Overview Table 107. Q3 Medical Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Q3 Medical Biodegradable Coronary Stents Product Portfolio Table 109. Q3 Medical Recent Development Table 110. Lepu Medical Company Information Table 111. Lepu Medical Business Overview Table 112. Lepu Medical Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Lepu Medical Biodegradable Coronary Stents Product Portfolio Table 114. Lepu Medical Recent Development Table 115. Kyoto Medical Company Information Table 116. Kyoto Medical Business Overview Table 117. Kyoto Medical Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Kyoto Medical Biodegradable Coronary Stents Product Portfolio Table 119. Kyoto Medical Recent Development Table 120. Elixir Medical Company Information Table 121. Elixir Medical Business Overview Table 122. Elixir Medical Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Elixir Medical Biodegradable Coronary Stents Product Portfolio Table 124. Elixir Medical Recent Development Table 125. Cardionovum Company Information Table 126. Cardionovum Business Overview Table 127. Cardionovum Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Cardionovum Biodegradable Coronary Stents Product Portfolio Table 129. Cardionovum Recent Development Table 130. Biotronik Company Information Table 131. Biotronik Business Overview Table 132. Biotronik Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Biotronik Biodegradable Coronary Stents Product Portfolio Table 134. Biotronik Recent Development Table 135. Arterius Company Information Table 136. Arterius Business Overview Table 137. Arterius Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Arterius Biodegradable Coronary Stents Product Portfolio Table 139. Arterius Recent Development Table 140. AMG International Company Information Table 141. AMG International Business Overview Table 142. AMG International Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 143. AMG International Biodegradable Coronary Stents Product Portfolio Table 144. AMG International Recent Development Table 145. Amaranth Medical Company Information Table 146. Amaranth Medical Business Overview Table 147. Amaranth Medical Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 148. Amaranth Medical Biodegradable Coronary Stents Product Portfolio Table 149. Amaranth Medical Recent Development Table 150. 3M Company Information Table 151. 3M Business Overview Table 152. 3M Biodegradable Coronary Stents Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 153. 3M Biodegradable Coronary Stents Product Portfolio Table 154. 3M Recent Development Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Biodegradable Coronary Stents Distributors List Table 158. Biodegradable Coronary Stents Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Biodegradable Coronary Stents Product Image Figure 2. Global Biodegradable Coronary Stents Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biodegradable Coronary Stents Sales Value (2021-2032) & (US$ Million) Figure 4. Global Biodegradable Coronary Stents Sales (2021-2032) & (Units) Figure 5. Global Biodegradable Coronary Stents Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Biodegradable Coronary Stents Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Polylactic Acid (PLA) Image Figure 10. Magnesium Alloys Image Figure 11. Others Image Figure 12. Global Biodegradable Coronary Stents Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Biodegradable Coronary Stents Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Biodegradable Coronary Stents Sales Volume Share by Type (2021-2032) Figure 15. Global Biodegradable Coronary Stents Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Biodegradable Coronary Stents Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Biodegradable Coronary Stents Sales Value Share by Type (2021-2032) Figure 18. Percutaneous Coronary Intervention (PCI) Image Figure 19. Post-Procedure Management Image Figure 20. Drug-Eluting Image Figure 21. Global Biodegradable Coronary Stents Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 22. Global Biodegradable Coronary Stents Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Biodegradable Coronary Stents Sales Volume Share by Application (2021-2032) Figure 24. Global Biodegradable Coronary Stents Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Biodegradable Coronary Stents Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Biodegradable Coronary Stents Sales Value Share by Application (2021-2032) Figure 27. Global Biodegradable Coronary Stents Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 28. Global Biodegradable Coronary Stents Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Biodegradable Coronary Stents Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Biodegradable Coronary Stents Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Biodegradable Coronary Stents Sales Value (2021-2032) & (US$ Million) Figure 32. North America Biodegradable Coronary Stents Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Biodegradable Coronary Stents Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Biodegradable Coronary Stents Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Biodegradable Coronary Stents Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Biodegradable Coronary Stents Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Biodegradable Coronary Stents Sales Value (2021-2032) & (US$ Million) Figure 38. South America Biodegradable Coronary Stents Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Biodegradable Coronary Stents Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Biodegradable Coronary Stents Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Biodegradable Coronary Stents Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Biodegradable Coronary Stents Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Polylactic Acid (PLA)
  • Magnesium Alloys
  • Others
Applications
  • Percutaneous Coronary Intervention (PCI)
  • Post-Procedure Management
  • Drug-Eluting
Companies covered
  • Abbott
  • Terumo
  • Shandong Huaan Biotechnology
  • Boston Scientific
  • Wego Healthcare
  • SMT
  • SINOMED
  • REVA Medical (1)
  • Q3 Medical
  • Lepu Medical
  • Kyoto Medical
  • Elixir Medical
  • Cardionovum
  • Biotronik
  • Arterius
  • AMG International
  • Amaranth Medical
  • 3M

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Biodegradable Coronary Stents Sales Value (2021-2032)
  4. 1.2.2 Global Biodegradable Coronary Stents Sales Volume (2021-2032)
  5. 1.2.3 Global Biodegradable Coronary Stents Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Biodegradable Coronary Stents Market Dynamics
  1. 2.1 Biodegradable Coronary Stents Industry Trends
  2. 2.2 Biodegradable Coronary Stents Industry Drivers
  3. 2.3 Biodegradable Coronary Stents Industry Opportunities and Challenges
  4. 2.4 Biodegradable Coronary Stents Industry Restraints
3 Biodegradable Coronary Stents Market by Company
  1. 3.1 Global Biodegradable Coronary Stents Company Revenue Ranking in 2025
  2. 3.2 Global Biodegradable Coronary Stents Revenue by Company (2021-2026)
  3. 3.3 Global Biodegradable Coronary Stents Sales Volume by Company (2021-2026)
  4. 3.4 Global Biodegradable Coronary Stents Average Price by Company (2021-2026)
  5. 3.5 Global Biodegradable Coronary Stents Company Ranking (2024-2026)
  6. 3.6 Global Biodegradable Coronary Stents Company Manufacturing Base and Headquarters
  7. 3.7 Global Biodegradable Coronary Stents Company Product Type and Application
  8. 3.8 Global Biodegradable Coronary Stents Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Biodegradable Coronary Stents Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Biodegradable Coronary Stents Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Biodegradable Coronary Stents Market by Type
  1. 4.1 Biodegradable Coronary Stents Type Introduction
  2. 4.1.1 Polylactic Acid (PLA)
  3. 4.1.2 Magnesium Alloys
  4. 4.1.3 Others
  5. 4.2 Global Biodegradable Coronary Stents Sales Volume by Type
  6. 4.2.1 Global Biodegradable Coronary Stents Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Biodegradable Coronary Stents Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Biodegradable Coronary Stents Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Biodegradable Coronary Stents Sales Value by Type
  10. 4.3.1 Global Biodegradable Coronary Stents Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Biodegradable Coronary Stents Sales Value by Type (2021-2032)
  12. 4.3.3 Global Biodegradable Coronary Stents Sales Value Share by Type (2021-2032)
5 Biodegradable Coronary Stents Market by Application
  1. 5.1 Biodegradable Coronary Stents Application Introduction
  2. 5.1.1 Percutaneous Coronary Intervention (PCI)
  3. 5.1.2 Post-Procedure Management
  4. 5.1.3 Drug-Eluting
  5. 5.2 Global Biodegradable Coronary Stents Sales Volume by Application
  6. 5.2.1 Global Biodegradable Coronary Stents Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biodegradable Coronary Stents Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Biodegradable Coronary Stents Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Biodegradable Coronary Stents Sales Value by Application
  10. 5.3.1 Global Biodegradable Coronary Stents Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Biodegradable Coronary Stents Sales Value by Application (2021-2032)
  12. 5.3.3 Global Biodegradable Coronary Stents Sales Value Share by Application (2021-2032)
6 Biodegradable Coronary Stents Regional Sales and Value Analysis
  1. 6.1 Global Biodegradable Coronary Stents Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biodegradable Coronary Stents Sales by Region (2021-2032)
  3. 6.2.1 Global Biodegradable Coronary Stents Sales by Region: 2021-2026
  4. 6.2.2 Global Biodegradable Coronary Stents Sales by Region (2027-2032)
  5. 6.3 Global Biodegradable Coronary Stents Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Biodegradable Coronary Stents Sales Value by Region (2021-2032)
  7. 6.4.1 Global Biodegradable Coronary Stents Sales Value by Region: 2021-2026
  8. 6.4.2 Global Biodegradable Coronary Stents Sales Value by Region (2027-2032)
  9. 6.5 Global Biodegradable Coronary Stents Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Biodegradable Coronary Stents Sales Value (2021-2032)
  12. 6.6.2 North America Biodegradable Coronary Stents Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Biodegradable Coronary Stents Sales Value (2021-2032)
  15. 6.7.2 Europe Biodegradable Coronary Stents Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Biodegradable Coronary Stents Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Biodegradable Coronary Stents Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Biodegradable Coronary Stents Sales Value (2021-2032)
  21. 6.9.2 South America Biodegradable Coronary Stents Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Biodegradable Coronary Stents Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Biodegradable Coronary Stents Sales Value Share by Country, 2025 VS 2032
7 Biodegradable Coronary Stents Country-level Sales and Value Analysis
  1. 7.1 Global Biodegradable Coronary Stents Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biodegradable Coronary Stents Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Biodegradable Coronary Stents Sales by Country (2021-2032)
  4. 7.3.1 Global Biodegradable Coronary Stents Sales by Country (2021-2026)
  5. 7.3.2 Global Biodegradable Coronary Stents Sales by Country (2027-2032)
  6. 7.4 Global Biodegradable Coronary Stents Sales Value by Country (2021-2032)
  7. 7.4.1 Global Biodegradable Coronary Stents Sales Value by Country (2021-2026)
  8. 7.4.2 Global Biodegradable Coronary Stents Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Biodegradable Coronary Stents Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Biodegradable Coronary Stents Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Biodegradable Coronary Stents Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Biodegradable Coronary Stents Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Terumo
  8. 8.2.1 Terumo Company Information
  9. 8.2.2 Terumo Business Overview
  10. 8.2.3 Terumo Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Terumo Biodegradable Coronary Stents Product Portfolio
  12. 8.2.5 Terumo Recent Developments
  13. 8.3 Shandong Huaan Biotechnology
  14. 8.3.1 Shandong Huaan Biotechnology Company Information
  15. 8.3.2 Shandong Huaan Biotechnology Business Overview
  16. 8.3.3 Shandong Huaan Biotechnology Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Huaan Biotechnology Biodegradable Coronary Stents Product Portfolio
  18. 8.3.5 Shandong Huaan Biotechnology Recent Developments
  19. 8.4 Boston Scientific
  20. 8.4.1 Boston Scientific Company Information
  21. 8.4.2 Boston Scientific Business Overview
  22. 8.4.3 Boston Scientific Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Boston Scientific Biodegradable Coronary Stents Product Portfolio
  24. 8.4.5 Boston Scientific Recent Developments
  25. 8.5 Wego Healthcare
  26. 8.5.1 Wego Healthcare Company Information
  27. 8.5.2 Wego Healthcare Business Overview
  28. 8.5.3 Wego Healthcare Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Wego Healthcare Biodegradable Coronary Stents Product Portfolio
  30. 8.5.5 Wego Healthcare Recent Developments
  31. 8.6 SMT
  32. 8.6.1 SMT Company Information
  33. 8.6.2 SMT Business Overview
  34. 8.6.3 SMT Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 SMT Biodegradable Coronary Stents Product Portfolio
  36. 8.6.5 SMT Recent Developments
  37. 8.7 SINOMED
  38. 8.7.1 SINOMED Company Information
  39. 8.7.2 SINOMED Business Overview
  40. 8.7.3 SINOMED Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 SINOMED Biodegradable Coronary Stents Product Portfolio
  42. 8.7.5 SINOMED Recent Developments
  43. 8.8 REVA Medical (1)
  44. 8.8.1 REVA Medical (1) Company Information
  45. 8.8.2 REVA Medical (1) Business Overview
  46. 8.8.3 REVA Medical (1) Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 REVA Medical (1) Biodegradable Coronary Stents Product Portfolio
  48. 8.8.5 REVA Medical (1) Recent Developments
  49. 8.9 Q3 Medical
  50. 8.9.1 Q3 Medical Company Information
  51. 8.9.2 Q3 Medical Business Overview
  52. 8.9.3 Q3 Medical Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Q3 Medical Biodegradable Coronary Stents Product Portfolio
  54. 8.9.5 Q3 Medical Recent Developments
  55. 8.10 Lepu Medical
  56. 8.10.1 Lepu Medical Company Information
  57. 8.10.2 Lepu Medical Business Overview
  58. 8.10.3 Lepu Medical Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Lepu Medical Biodegradable Coronary Stents Product Portfolio
  60. 8.10.5 Lepu Medical Recent Developments
  61. 8.11 Kyoto Medical
  62. 8.11.1 Kyoto Medical Company Information
  63. 8.11.2 Kyoto Medical Business Overview
  64. 8.11.3 Kyoto Medical Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Kyoto Medical Biodegradable Coronary Stents Product Portfolio
  66. 8.11.5 Kyoto Medical Recent Developments
  67. 8.12 Elixir Medical
  68. 8.12.1 Elixir Medical Company Information
  69. 8.12.2 Elixir Medical Business Overview
  70. 8.12.3 Elixir Medical Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Elixir Medical Biodegradable Coronary Stents Product Portfolio
  72. 8.12.5 Elixir Medical Recent Developments
  73. 8.13 Cardionovum
  74. 8.13.1 Cardionovum Company Information
  75. 8.13.2 Cardionovum Business Overview
  76. 8.13.3 Cardionovum Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Cardionovum Biodegradable Coronary Stents Product Portfolio
  78. 8.13.5 Cardionovum Recent Developments
  79. 8.14 Biotronik
  80. 8.14.1 Biotronik Company Information
  81. 8.14.2 Biotronik Business Overview
  82. 8.14.3 Biotronik Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Biotronik Biodegradable Coronary Stents Product Portfolio
  84. 8.14.5 Biotronik Recent Developments
  85. 8.15 Arterius
  86. 8.15.1 Arterius Company Information
  87. 8.15.2 Arterius Business Overview
  88. 8.15.3 Arterius Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Arterius Biodegradable Coronary Stents Product Portfolio
  90. 8.15.5 Arterius Recent Developments
  91. 8.16 AMG International
  92. 8.16.1 AMG International Company Information
  93. 8.16.2 AMG International Business Overview
  94. 8.16.3 AMG International Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 AMG International Biodegradable Coronary Stents Product Portfolio
  96. 8.16.5 AMG International Recent Developments
  97. 8.17 Amaranth Medical
  98. 8.17.1 Amaranth Medical Company Information
  99. 8.17.2 Amaranth Medical Business Overview
  100. 8.17.3 Amaranth Medical Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Amaranth Medical Biodegradable Coronary Stents Product Portfolio
  102. 8.17.5 Amaranth Medical Recent Developments
  103. 8.18 3M
  104. 8.18.1 3M Company Information
  105. 8.18.2 3M Business Overview
  106. 8.18.3 3M Biodegradable Coronary Stents Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 3M Biodegradable Coronary Stents Product Portfolio
  108. 8.18.5 3M Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biodegradable Coronary Stents Value Chain Analysis
  2. 9.1.1 Biodegradable Coronary Stents Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biodegradable Coronary Stents Sales Mode & Process
  6. 9.2 Biodegradable Coronary Stents Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biodegradable Coronary Stents Distributors
  9. 9.2.3 Biodegradable Coronary Stents Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst